Molina Healthcare (MOH) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.51
- EPS estimate
- $1.39
- EPS surprise
- +8.58%
- Revenue surprise
- +0.39%
- Revenue
- $10.9B
- Revenue estimate
- $10.8B
- Reported
- Jul 22, 2026
Molina Healthcare reported Q2 2026 results on July 22, 2026. Earnings per share were $1.51, ahead of the $1.39 estimate by 8.58%. Revenue of $10.9 billion was 0.39% above the $10.8 billion consensus. Compared with Q2 2025, though, EPS fell about 72% from $5.48 and revenue slipped from $11.4 billion.
The table shows a sharp break in 2025. Annual EPS rose from $17.91 in 2022 to $20.89 in 2023 and $22.65 in 2024, then fell to $10.65 in 2025, about 53% lower. Q4 2025 was a loss of $2.75 per share against a $0.34 estimate, the only loss in the table. Revenue moved the other way, growing from about $32.0 billion in 2022 to about $45.4 billion in 2025, with a quarterly high of $11.5 billion in Q3 2025. The first half of 2026 totals $3.86 per share, about 67% below the first half of 2025. Molina beat the EPS estimate in 16 of the last 20 quarters, including the two most recent.
Q3 results came between October 22 and October 27 in each of the past five years. That points to late October 2026 for the next report, which will show whether earnings move back toward earlier levels.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 22, 2026 | $1.39 | $1.51 | +8.58% | $10.9B | SEC |
| Q1 2026 | Apr 22, 2026 | $1.90 | $2.35 | +23.63% | $10.8B | SEC |
| Q4 2025 | Feb 5, 2026 | $0.34 | −$2.75 | −919.43% | $11.4B | SEC |
| Q3 2025 | Oct 22, 2025 | $3.90 | $1.84 | −52.87% | $11.5B | SEC |
| Q2 2025 | Jul 23, 2025 | $5.62 | $5.48 | −2.46% | $11.4B | SEC |
| Q1 2025 | Apr 23, 2025 | $5.97 | $6.08 | +1.86% | $11.1B | SEC |
| Q4 2024 | Feb 5, 2025 | $5.75 | $5.05 | −12.14% | $10.5B | SEC |
| Q3 2024 | Oct 23, 2024 | $5.81 | $6.01 | +3.53% | $10.3B | SEC |
| Q2 2024 | Jul 24, 2024 | $5.56 | $5.86 | +5.33% | $9.9B | SEC |
| Q1 2024 | Apr 24, 2024 | $5.68 | $5.73 | +0.80% | $9.9B | SEC |
| Q4 2023 | Feb 7, 2024 | $4.34 | $4.38 | +0.83% | $9.0B | SEC |
| Q3 2023 | Oct 25, 2023 | $4.88 | $5.05 | +3.48% | $8.5B | SEC |
| Q2 2023 | Jul 26, 2023 | $5.10 | $5.65 | +10.81% | $8.3B | SEC |
| Q1 2023 | Apr 26, 2023 | $5.19 | $5.81 | +11.88% | $8.1B | SEC |
| Q4 2022 | Feb 8, 2023 | $4.02 | $4.10 | +2.08% | $8.2B | SEC |
| Q3 2022 | Oct 26, 2022 | $4.22 | $4.36 | +3.40% | $7.9B | SEC |
| Q2 2022 | Jul 27, 2022 | $4.33 | $4.55 | +5.04% | $8.1B | SEC |
| Q1 2022 | Apr 27, 2022 | $4.66 | $4.90 | +5.17% | $7.8B | SEC |
| Q4 2021 | Feb 9, 2022 | $2.75 | $2.88 | +4.77% | $7.4B | SEC |
| Q3 2021 | Oct 27, 2021 | $2.80 | $2.83 | +1.04% | $7.0B | SEC |
Quarterly revenue
Frequently asked questions
When did Molina Healthcare (MOH) last report earnings?
Molina Healthcare last reported on Jul 22, 2026, covering fiscal Q2 2026.
Did MOH beat earnings estimates?
Yes. Molina Healthcare reported EPS of $1.51 for Q2 2026 against a $1.39 estimate — a 8.58% beat.
How much revenue did MOH report last quarter?
Molina Healthcare reported $10.9B in revenue for Q2 2026, against a consensus estimate of $10.8B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.